Obio Technology (Shanghai) Corp., Ltd. (SHSE:688238) shares have had a really impressive month, gaining 27% after a shaky period beforehand. Unfortunately, the gains of the last month did little to right the losses of the last year with the stock still down 13% over that time.
After such a large jump in price, when almost half of the companies in China’s Life Sciences industry have price-to-sales ratios (or “P/S”) below 5.6x, you may consider Obio Technology (Shanghai) as a stock not worth researching with its 15x P/S ratio. Nonetheless, we’d need to dig a little deeper to determine if there is a rational basis for the highly elevated P/S.
See our latest analysis for Obio Technology (Shanghai)
How Has Obio Technology (Shanghai) Performed Recently?
Obio Technology (Shanghai) certainly has been doing a good job lately as its revenue growth has been positive…
